{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:18:06Z","timestamp":1793744286338,"version":"4.6.1"},"reference-count":76,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,11]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Altered lipid metabolism enables growth of acute myeloid leukemia (AML) cells. Although mitochondrial lipid oxidation is well characterized, the contribution of peroxisomal fatty acid oxidation (pFAO) is unclear. In this study, we demonstrate that AML cells upregulate the peroxisomal very long-chain fatty acid (VLCFA) transporter ABCD1 and increase endogenous levels of pFAO relative to healthy hematopoietic cells. Genetic silencing or pharmacological inhibition of ABCD1, with eicosenol, impairs pFAO causing accumulation of VLCFAs and selective AML cell death in vitro and in vivo. Loss of ABCD1 disrupts peroxisomal fatty acid import and lipid homeostasis in AML, whereas normal progenitors remain viable by upregulating glycolysis. In murine models, ABCD1 inhibition with eicosenol reduces leukemia burden and prolongs survival without toxicity. These findings identify ABCD1 as a regulator of pFAO and a novel anti-AML therapeutic target.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031202","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:04:17Z","timestamp":1772129057000},"page":"2930-2943","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Targeting ABCD1 inhibits peroxisomal fatty acid oxidation to selectively eliminate acute myeloid leukemia cells"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7274-3397","authenticated-orcid":false,"given":"Ekaterina N.","family":"Parfenova","sequence":"first","affiliation":[{"name":"1Department of Food Science, University of Guelph, Guelph, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolina","family":"Vrdoljak","sequence":"additional","affiliation":[{"name":"1Department of Food Science, University of Guelph, Guelph, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drake A.","family":"Mosca","sequence":"additional","affiliation":[{"name":"1Department of Food Science, University of Guelph, Guelph, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2085-2396","authenticated-orcid":false,"given":"Juan J.","family":"Aristizabal-Henao","sequence":"additional","affiliation":[{"name":"2BPGbio Inc, Framingham, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5678-0072","authenticated-orcid":false,"given":"Michael A.","family":"Kiebish","sequence":"additional","affiliation":[{"name":"2BPGbio Inc, Framingham, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9089-8816","authenticated-orcid":false,"given":"Mark D.","family":"Minden","sequence":"additional","affiliation":[{"name":"3Princess Margaret Cancer Center, Ontario Cancer Institute, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2431-4368","authenticated-orcid":false,"given":"Paul A.","family":"Spagnuolo","sequence":"additional","affiliation":[{"name":"1Department of Food Science, University of Guelph, Guelph, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2026061111220665900_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab"},{"issue":"25","key":"2026061111220665900_bib2","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1182\/blood.2020008551","article-title":"Very long chain fatty acid metabolism is required in acute myeloid leukemia","volume":"137","author":"Tcheng","year":"2021","journal-title":"Blood"},{"issue":"12","key":"2026061111220665900_bib3","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","author":"Stevens","year":"2020","journal-title":"Nat Cancer"},{"issue":"12","key":"2026061111220665900_bib4","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1158\/0008-5472.CAN-14-2676","article-title":"Targeting mitochondria with avocatin B induces selective leukemia cell death","volume":"75","author":"Lee","year":"2015","journal-title":"Cancer Res"},{"issue":"7","key":"2026061111220665900_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"issue":"1","key":"2026061111220665900_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12885-023-10816-3","article-title":"SLC27A2 mediates FAO in colorectal cancer through nongenic crosstalk regulation of the PPARs pathway","volume":"23","author":"Shang","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"2026061111220665900_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1172\/JCI38942","article-title":"Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction","volume":"120","author":"Samudio","year":"2010","journal-title":"J Clin Invest"},{"issue":"5","key":"2026061111220665900_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2010.30.1820","article-title":"Therapeutic advances in acute myeloid leukemia","volume":"29","author":"Burnett","year":"2011","journal-title":"J Clin Oncol"},{"issue":"11","key":"2026061111220665900_bib9","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s43018-021-00264-y","article-title":"Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia","volume":"2","author":"Bosc","year":"2021","journal-title":"Nat Cancer"},{"issue":"1","key":"2026061111220665900_bib10","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41467-022-29039-4","article-title":"Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia","volume":"13","author":"Anderson","year":"2022","journal-title":"Nat Commun"},{"issue":"16","key":"2026061111220665900_bib11","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-21-0611","article-title":"Vorasidenib, a dual inhibitor of mutant IDH1\/2, in recurrent or progressive glioma; results of a first-in-human phase I trial","volume":"27","author":"Mellinghoff","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"18","key":"2026061111220665900_bib12","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.3390\/cancers15184476","article-title":"MitoTam-01 trial: mitochondrial targeting as plausible approach to cancer therapy. Comment on Yap et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat. Med. 2023, 29, 115-126","volume":"15","author":"Neuzil","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2026061111220665900_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41420-025-02554-1","article-title":"The role and mechanism of fatty acid oxidation in cancer drug resistance","volume":"11","author":"Lei","year":"2025","journal-title":"Cell Death Discov"},{"key":"2026061111220665900_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-030-60204-8_5","article-title":"Fatty acid oxidation in peroxisomes: enzymology, metabolic crosstalk with other organelles and peroxisomal disorders","volume":"1299","author":"Wanders","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"2026061111220665900_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10545-015-9819-7","article-title":"Peroxisome-mitochondria interplay and disease","volume":"38","author":"Schrader","year":"2015","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2026061111220665900_bib16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1152\/physrev.00051.2021","article-title":"The physiological functions of human peroxisomes","volume":"103","author":"Wanders","year":"2023","journal-title":"Physiol Rev"},{"issue":"7","key":"2026061111220665900_bib17","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3390\/cells9071692","article-title":"Peroxisome metabolism in cancer","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"issue":"3","key":"2026061111220665900_bib18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cmet.2014.01.002","article-title":"Peroxisomes: a nexus for lipid metabolism and cellular signaling","volume":"19","author":"Lodhi","year":"2014","journal-title":"Cell Metab"},{"issue":"9","key":"2026061111220665900_bib19","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.bbalip.2013.06.007","article-title":"Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient","volume":"1831","author":"Violante","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2026061111220665900_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbamcr.2014.11.017","article-title":"Mitochondria in peroxisome-deficient hepatocytes exhibit impaired respiration, depleted DNA, and PGC-1\u03b1 independent proliferation","volume":"1853","author":"Peeters","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2026061111220665900_bib21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jnc.12992","article-title":"ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy","volume":"133","author":"Baarine","year":"2015","journal-title":"J Neurochem"},{"issue":"5","key":"2026061111220665900_bib22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41416-023-02557-8","article-title":"Peroxisomal \u03b2-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer","volume":"130","author":"Mah","year":"2024","journal-title":"Br J Cancer"},{"issue":"3","key":"2026061111220665900_bib23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41375-025-02522-9","article-title":"Targeting ABCD1-ACOX1-MET\/IGF1R axis suppresses multiple myeloma","volume":"39","author":"Han","year":"2025","journal-title":"Leukemia"},{"issue":"2","key":"2026061111220665900_bib24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41375-023-02103-8","article-title":"ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia","volume":"38","author":"Tannoury","year":"2024","journal-title":"Leukemia"},{"issue":"11","key":"2026061111220665900_bib25","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/cdd.2017.115","article-title":"Peroxisomes protect lymphoma cells from HDAC inhibitor-mediated apoptosis","volume":"24","author":"Dahabieh","year":"2017","journal-title":"Cell Death Differ"},{"issue":"9","key":"2026061111220665900_bib26","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.34067\/KID.0003772021","article-title":"Peroxisomal L-bifunctional protein (EHHADH) deficiency causes male-specific kidney hypertrophy and proximal tubular injury in mice","volume":"2","author":"Ranea-Robles","year":"2021","journal-title":"Kidney360"},{"issue":"2","key":"2026061111220665900_bib27","doi-asserted-by":"crossref","first-page":"102845","DOI":"10.1016\/j.jbc.2022.102845","article-title":"Targeting peroxisomal fatty acid oxidation improves hepatic steatosis and insulin resistance in obese mice","volume":"299","author":"Yao","year":"2023","journal-title":"J Biol Chem"},{"issue":"1","key":"2026061111220665900_bib28","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1038\/s41467-024-48471-2","article-title":"Liver ACOX1 regulates levels of circulating lipids that promote metabolic health through adipose remodeling","volume":"15","author":"Lu","year":"2024","journal-title":"Nat Commun"},{"issue":"9","key":"2026061111220665900_bib29","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1074\/jbc.M116.763532","article-title":"Specific inhibition of acyl-CoA oxidase-1 by an acetylenic acid improves hepatic lipid and reactive oxygen species (ROS) metabolism in rats fed a high fat diet","volume":"292","author":"Zeng","year":"2017","journal-title":"J Biol Chem"},{"key":"2026061111220665900_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0076-6879(81)72021-4","article-title":"Assay of peroxisomal beta-oxidation of fatty acids","volume":"72","author":"Lazarow","year":"1981","journal-title":"Methods Enzymol"},{"issue":"8","key":"2026061111220665900_bib31","doi-asserted-by":"crossref","first-page":"158726","DOI":"10.1016\/j.bbalip.2020.158726","article-title":"Catalase is required for peroxisome maintenance during adipogenesis","volume":"1865","author":"Nitta","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2026061111220665900_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fphys.2012.00108","article-title":"Effects of peroxisomal catalase inhibition on mitochondrial function","volume":"3","author":"Walton","year":"2012","journal-title":"Front Physiol"},{"issue":"12","key":"2026061111220665900_bib33","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s42255-021-00489-2","article-title":"Peroxisomal \u03b2-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis","volume":"3","author":"Ding","year":"2021","journal-title":"Nat Metab"},{"issue":"11","key":"2026061111220665900_bib34","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1158\/1541-7786.MCR-21-1032","article-title":"Glutamine metabolism mediates sensitivity to respiratory complex II inhibition in acute myeloid leukemia","volume":"20","author":"Roma","year":"2022","journal-title":"Mol Cancer Res"},{"issue":"1","key":"2026061111220665900_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40170-025-00402-5","article-title":"Pharmacological inhibition of peroxisome proliferation-activated receptor delta (PPAR\u03b4) imparts selective leukemia cell death","volume":"13","author":"Yang","year":"2025","journal-title":"Cancer Metab"},{"issue":"12","key":"2026061111220665900_bib36","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.3390\/ijms25126517","article-title":"Pseudolaric acid B targets CD147 to selectively kill acute myeloid leukemia cells","volume":"25","author":"Zou","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"766","key":"2026061111220665900_bib37","doi-asserted-by":"crossref","first-page":"eadn1285","DOI":"10.1126\/scitranslmed.adn1285","article-title":"Spermidine metabolism regulates leukemia stem and progenitor cell function through KAT7 expression in patient-derived mouse models","volume":"16","author":"Rondeau","year":"2024","journal-title":"Sci Transl Med"},{"issue":"4","key":"2026061111220665900_bib38","first-page":"339","article-title":"Interactions between nutraceutical supplements and standard acute myeloid leukemia chemotherapeutics","volume":"18","author":"Angka","year":"2015","journal-title":"J Pharm Sci"},{"issue":"27","key":"2026061111220665900_bib39","doi-asserted-by":"crossref","first-page":"7373","DOI":"10.1007\/s00216-020-02910-3","article-title":"Nontargeted lipidomics of novel human plasma reference materials: hypertriglyceridemic, diabetic, and African-American","volume":"412","author":"Aristizabal-Henao","year":"2020","journal-title":"Anal Bioanal Chem"},{"issue":"24","key":"2026061111220665900_bib40","doi-asserted-by":"crossref","first-page":"1900688","DOI":"10.1002\/mnfr.201900688","article-title":"Avocatin B protects against lipotoxicity and improves insulin sensitivity in diet-induced obesity","volume":"63","author":"Ahmed","year":"2019","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"2026061111220665900_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.taap.2008.06.004","article-title":"Progeric effects of catalase inactivation in human cells","volume":"232","author":"Koepke","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"2026061111220665900_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00418-018-1722-5","article-title":"The peroxisome: an update on mysteries 2.0","volume":"150","author":"Islinger","year":"2018","journal-title":"Histochem Cell Biol"},{"issue":"10","key":"2026061111220665900_bib43","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.bbamcr.2017.07.013","article-title":"The peroxisomal import receptor PEX5 functions as a stress sensor, retaining catalase in the cytosol in times of oxidative stress","volume":"1864","author":"Walton","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"4","key":"2026061111220665900_bib44","doi-asserted-by":"crossref","first-page":"E986","DOI":"10.1152\/ajpendo.00399.2006","article-title":"Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance","volume":"293","author":"Noland","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2026061111220665900_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0024-3205(92)90218-E","article-title":"Selective inhibition of hepatic peroxisomal fatty acid beta-oxidation by enoximone","volume":"51","author":"Abdel-aleem","year":"1992","journal-title":"Life Sci"},{"issue":"2","key":"2026061111220665900_bib46","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.14440\/jbm.2022.374","article-title":"Methodology for measuring oxidative capacity of isolated peroxisomes in the Seahorse assay","volume":"9","author":"Stork","year":"2022","journal-title":"J Biol Methods"},{"key":"2026061111220665900_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1385\/CBB:32:1-3:131","article-title":"The 70-kDa peroxisomal membrane protein (PMP70), an ATP-binding cassette transporter","volume":"32","author":"Imanaka","year":"2000","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"2026061111220665900_bib48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41419-025-07572-6","article-title":"Peroxisomal membrane protein PMP70 confers drug resistance in colorectal cancer","volume":"16","author":"Yin","year":"2025","journal-title":"Cell Death Dis"},{"issue":"3","key":"2026061111220665900_bib49","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1096\/fj.201801498R","article-title":"Peroxisomes can oxidize medium- and long-chain fatty acids through a pathway involving ABCD3 and HSD17B4","volume":"33","author":"Violante","year":"2019","journal-title":"FASEB J"},{"key":"2026061111220665900_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.metabol.2019.06.009","article-title":"Peroxisomal gene and protein expression increase in response to a high-lipid challenge in human skeletal muscle","volume":"98","author":"Huang","year":"2019","journal-title":"Metabolism"},{"key":"2026061111220665900_bib51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-1-4615-3426-6_30","article-title":"Very long-chain fatty acids in peroxisomal disease","volume":"318","author":"Poulos","year":"1992","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"2026061111220665900_bib52","doi-asserted-by":"crossref","first-page":"15093","DOI":"10.1038\/s41598-020-71248-8","article-title":"Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy","volume":"10","author":"Rattay","year":"2020","journal-title":"Sci Rep"},{"issue":"18","key":"2026061111220665900_bib53","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","article-title":"Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity","volume":"81","author":"Yoon","year":"2021","journal-title":"Mol Cell"},{"issue":"1","key":"2026061111220665900_bib54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic\/adrenic phosphatidylethanolamines navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat Chem Biol"},{"issue":"3","key":"2026061111220665900_bib55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol"},{"issue":"3","key":"2026061111220665900_bib56","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"13","key":"2026061111220665900_bib57","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood-2014-08-594408","article-title":"AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress","volume":"125","author":"Sriskanthadevan","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2026061111220665900_bib58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.20517\/cdr.2022.133","article-title":"Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment","volume":"6","author":"Tabe","year":"2023","journal-title":"Cancer Drug Resist"},{"key":"2026061111220665900_bib59","doi-asserted-by":"crossref","first-page":"807266","DOI":"10.3389\/fonc.2022.807266","article-title":"Exploring the metabolic landscape of AML: from haematopoietic stem cells to myeloblasts and leukaemic stem cells","volume":"12","author":"Mesbahi","year":"2022","journal-title":"Front Oncol"},{"issue":"7","key":"2026061111220665900_bib60","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"issue":"1","key":"2026061111220665900_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"issue":"1","key":"2026061111220665900_bib62","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1038\/s41598-024-58689-1","article-title":"SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia","volume":"14","author":"\u00c5backa","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"2026061111220665900_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/BJ20121110","article-title":"Identification of a novel malonyl-CoA IC50 for CPT-1: implications for predicting in vivo fatty acid oxidation rates","volume":"448","author":"Smith","year":"2012","journal-title":"Biochem J"},{"issue":"16","key":"2026061111220665900_bib64","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood-2014-12-617498","article-title":"Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias","volume":"126","author":"Ricciardi","year":"2015","journal-title":"Blood"},{"issue":"8","key":"2026061111220665900_bib65","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/cells8080805","article-title":"Metabolic plasticity of acute myeloid leukemia","volume":"8","author":"Kreitz","year":"2019","journal-title":"Cells"},{"key":"2026061111220665900_bib66","doi-asserted-by":"crossref","first-page":"1155774","DOI":"10.3389\/fonc.2023.1155774","article-title":"Understanding mitochondrial dynamics and metabolic plasticity in cancer stem cells: recent advances in cancer treatment and potential therapeutic approaches","volume":"13","author":"Darvin","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"2026061111220665900_bib67","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2026061111220665900_bib68","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/toxsci\/kfae055","article-title":"Drug-induced impairment of mitochondrial fatty acid oxidation and steatosis: assessment of causal relationship with 45 pharmaceuticals","volume":"200","author":"Buron","year":"2024","journal-title":"Toxicol Sci"},{"issue":"3-4","key":"2026061111220665900_bib69","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.livres.2019.06.001","article-title":"Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis","volume":"3","author":"Fromenty","year":"2019","journal-title":"Liver Res"},{"issue":"11","key":"2026061111220665900_bib70","doi-asserted-by":"crossref","first-page":"jcs224766","DOI":"10.1242\/jcs.224766","article-title":"Peroxisomes control mitochondrial dynamics and the mitochondrion-dependent apoptosis pathway","volume":"132","author":"Tanaka","year":"2019","journal-title":"J Cell Sci"},{"issue":"6756","key":"2026061111220665900_bib71","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1126\/science.adn2804","article-title":"ROS transfer at peroxisome-mitochondria contact regulates mitochondrial redox","volume":"389","author":"DiGiovanni","year":"2025","journal-title":"Science"},{"issue":"10","key":"2026061111220665900_bib72","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41388-021-01667-y","article-title":"Long chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation","volume":"40","author":"Ma","year":"2021","journal-title":"Oncogene"},{"issue":"10","key":"2026061111220665900_bib73","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.7150\/jca.93832","article-title":"ACOX2 serves as a favorable indicator related to lipid metabolism and oxidative stress for biochemical recurrence in prostate cancer","volume":"15","author":"Tan","year":"2024","journal-title":"J Cancer"},{"issue":"9","key":"2026061111220665900_bib74","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/cancers12092623","article-title":"The Role of PPAR\u03b3 ligands in breast cancer: from basic research to clinical studies","volume":"12","author":"Augimeri","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"32","key":"2026061111220665900_bib75","doi-asserted-by":"crossref","first-page":"29681","DOI":"10.1074\/jbc.M103779200","article-title":"Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells","volume":"276","author":"Gupta","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"2026061111220665900_bib76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.prp.2016.09.002","article-title":"Low acyl-CoA synthetase 5 expression in colorectal carcinomas is prognostic for early tumour recurrence","volume":"213","author":"Hartmann","year":"2017","journal-title":"Pathol Res Pract"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/24\/2930\/2525755\/blood_bld-2025-031202-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/24\/2930\/2525755\/blood_bld-2025-031202-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:22:20Z","timestamp":1781191340000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/24\/2930\/566862\/Targeting-ABCD1-inhibits-peroxisomal-fatty-acid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":76,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2026,6,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031202","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,11]]},"published":{"date-parts":[[2026,6,11]]}}}